These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Do the current medical and economic times dictate the need for the "polypill"? Rifai L; Khan BV J Clin Hypertens (Greenwich); 2009 Dec; 11(12):775-6. PubMed ID: 20021541 [No Abstract] [Full Text] [Related]
4. Doxazosin arm of the ALLHAT study discontinued: how equal are antihypertensive drugs? Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial. Messerli FH; Grossman E Curr Hypertens Rep; 2000 Jun; 2(3):241-2. PubMed ID: 10981155 [No Abstract] [Full Text] [Related]
5. Managing established coronary heart disease. Moher M; Schofield T; Weston S; Fullard E BMJ; 1997 Jul; 315(7100):69-70. PubMed ID: 9240033 [No Abstract] [Full Text] [Related]
6. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?]. Kolenda KD Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107 [No Abstract] [Full Text] [Related]
7. Summaries for patients. Risk factors and treatment in women with coronary artery disease. Ann Intern Med; 2003 Jan; 138(2):I10. PubMed ID: 12529114 [No Abstract] [Full Text] [Related]
10. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642 [TBL] [Abstract][Full Text] [Related]
11. Should elderly individuals who frequently nap take beta-blockers and/or aspirin? Goldstein MR Arch Intern Med; 2000 Mar; 160(5):710; author reply 711-2. PubMed ID: 10724058 [No Abstract] [Full Text] [Related]
13. Secondary prevention of coronary heart disease in the elderly. Dornbrook-Lavender KA; Roth MT; Pieper JA Ann Pharmacother; 2003 Dec; 37(12):1867-76. PubMed ID: 14632542 [TBL] [Abstract][Full Text] [Related]
14. Secondary prevention in coronary heart disease: goal achievement and drug prescribing. Giverhaug T; Bruland C; Trovik T Pharm World Sci; 2005 Dec; 27(6):472-4. PubMed ID: 16341957 [TBL] [Abstract][Full Text] [Related]
15. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Vittinghoff E; Shlipak MG; Varosy PD; Furberg CD; Ireland CC; Khan SS; Blumenthal R; Barrett-Connor E; Hulley S; Ann Intern Med; 2003 Jan; 138(2):81-9. PubMed ID: 12529088 [TBL] [Abstract][Full Text] [Related]
16. CAD initiative begins at the hospital with medication, lifestyle interventions. Clin Resour Manag; 2001 Sep; 2(9):132-5, 129. PubMed ID: 11577511 [TBL] [Abstract][Full Text] [Related]
17. Secondary prevention of atherothrombotic or cryptogenic stroke. Tai WA; Albers GW Circulation; 2014 Jan; 129(4):527-31. PubMed ID: 24470474 [No Abstract] [Full Text] [Related]
18. Secondary prevention of coronary heart disease in older patients after the national service framework: population based study. Ramsay SE; Whincup PH; Lawlor DA; Papacosta O; Lennon LT; Thomas MC; Ebrahim S; Morris RW BMJ; 2006 Jan; 332(7534):144-5. PubMed ID: 16401630 [TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular protection and prevention in patients with cardiac conditions and diabetes]. Charpentier G; Puel J; Steg PG Presse Med; 2005 Oct; 34(18):1295-8. PubMed ID: 16269992 [TBL] [Abstract][Full Text] [Related]